Risk of type 2 diabetes after breast cancer treatment: a population-based cohort study in Denmark
BC was associated with excess risk of T2D, although of lower magnitude than previously reported. The excess risk was temporary and related to BC treatment but could also be influenced by obesity and heightened T2D diagnostic activity.
Authors
- Kasper Aalbæk Kjærgaard (ORCID: https://orcid.org/0000-0003-0614-7938)
- Signe Borgquist (ORCID: https://orcid.org/0000-0001-7938-8893)
- Henrik Toft Sørensen (ORCID: https://orcid.org/0000-0003-4299-7040)
- Astrid Kousholt
- Reimar W. Thomsen (ORCID: https://orcid.org/0000-0001-9135-3474)
- Kirsten M. Woolpert (ORCID: https://orcid.org/0000-0002-5536-7649)
- Deirdre Cronin‐Fenton (ORCID: https://orcid.org/0000-0001-9738-2284)
Institutions
- Aarhus University Hospital (DK)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1093/jnci/djae261
- Citations
- 3
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- Dagmar Marshalls Fond
- Kræftens Bekæmpelse
- Novo Nordisk
- Novo Nordisk Fonden